Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07850102
PHASE2
Brain Imaging of DSP-2342
Sponsor: Johns Hopkins University
View on ClinicalTrials.gov
Summary
The investigators aim to determine the effects of a novel drug on brain function and brain chemistry in patients with schizophrenia.
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2027-01-01
Completion Date
2028-06-30
Last Updated
2026-09-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
DSP-2342
a single oral dose of DSP-2342 on brain chemistry and brain activity in adults with schizophrenia.
Locations (1)
johns Hopkins University
Baltimore, Maryland, United States